Table 1. Baseline characteristics of the entire cohort.
| Features | Number (%) (n = 80) (100%) |
|
|---|---|---|
| Age median (range) | 57 years (39–78 years) | |
| Sex | Male | 49 (61.3) |
| Female | 31 (38.7) | |
| Performance status | 0 | 18 (22.5) |
| 1 | 55 (68.8) | |
| 2 | 7 (8.8) | |
| Histology | Squamous cell carcinoma | 80 (100) |
| Adenocarcinoma | 0 (0) | |
| Location | Lower thoracic | 38 (47.5) |
| Middle thoracic | 40 (50) | |
| Upper thoracic | 2 (2.5) | |
| Tumour length median (range) | 5.5 cm (1.7–13.1 cm) | |
| Clinical T stage | cT1b | 1 (1.3) |
| cT3 | 77 (96.3) | |
| cT4a | 2 (2.5) | |
| Clinical N stage | cN0 | 29 (36.3) |
| cN1 | 31 (38.8) | |
| cN2 | 19 (23.8) | |
| cN3 | 1 (1.3) | |
| Technique of RT | 3DCRT | 59 (73.8) |
| Rapid arc | 7 (8.8) | |
| Tomotherapy | 12 (15) | |
| Missing | 2 (2.4) | |
| CROSS eligible | Yes | 47 (58.7) |
| No | 33 (41.3) | |